Cargando…
234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria
BACKGROUND: Genomic tools permit a detailed analysis of antibiotic resistance determinants in bacteria, or resistome. Here we discuss variations in antibiotic resistance in K. pneumoniae (Kp) not explained by changes in the resistome METHODS: We compared Kp strains with divergent carbapenem and amin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810522/ http://dx.doi.org/10.1093/ofid/ofz360.309 |
_version_ | 1783462276276158464 |
---|---|
author | Rojas, Laura J Marshall, Steven Yasmin, Mohamad Rudin, Susan D Perez, Federico Donskey, Curtis Hecker, Michelle Bonomo, Robert A |
author_facet | Rojas, Laura J Marshall, Steven Yasmin, Mohamad Rudin, Susan D Perez, Federico Donskey, Curtis Hecker, Michelle Bonomo, Robert A |
author_sort | Rojas, Laura J |
collection | PubMed |
description | BACKGROUND: Genomic tools permit a detailed analysis of antibiotic resistance determinants in bacteria, or resistome. Here we discuss variations in antibiotic resistance in K. pneumoniae (Kp) not explained by changes in the resistome METHODS: We compared Kp strains with divergent carbapenem and aminoglycoside susceptibilities. After identification of bacteria, antibiotic susceptibility testing was performed according to CLSI guidelines. Draft genome sequences were generated using Illumina MiSeq (Nextera paired-end library) and assembled using CLC Genomics Workbench (CLC bio, Cambridge, MA). Resistome, plasmid types and MLST were investigated using the CGE platform (http://cge.cbs.dtu.dk), while capsular type and virulence genes were investigated using the Pasteur BIGsDB database (https://bigsdb.pasteur.fr). RESULTS: While receiving amoxicillin-clavulanate, a 44-year old man with diabetes mellitus and paraplegia with neurogenic bladder grewKp resistant to carbapenems and amikacin from urine. He was treated with fosfomycin and amikacin, followed by imipenem and plazomicin, prior to lithotripsy. Three months later, while off antibiotics, urine cultures grew Kp susceptible to carbapenems and amikacin (figure). Genetic comparison between resistant (November 20, 2018) and susceptible (January 30, 2019) strains revealed they were isogenic, only differing by 559 SNPs (table). Both were ST14, presented capsular type 16, and shared cehalosporinase (bla(SHV-28), bla(CTX-M-15), bla(TEM-1B), bla(OXA-1)) and aminoglycoside modifying enzyme (AME) (aph(3’’)-Ib, aph(6)-Id, aac(6’)-Ib-cr) genes. Although both had mutations in the outer membrane porin OmpK36, these differed (stop AA125 and frameshift AA183, respectively) CONCLUSION: Carbapenem resistance in the initial Kp is likely explained by overexpression of cephalosporinases in combination with changes in membrane permeability, while amikacin resistance is likely due to AMEs. Since no significant gene variation was observed in the susceptible Kp, reversal of resistance was likely due to decreased expression of cephalosporinases and AMEs after antibiotics were stopped. Incorporation of antibiotic history and host factors can explain clinically important changes in antibiotic resistance [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68105222019-10-28 234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria Rojas, Laura J Marshall, Steven Yasmin, Mohamad Rudin, Susan D Perez, Federico Donskey, Curtis Hecker, Michelle Bonomo, Robert A Open Forum Infect Dis Abstracts BACKGROUND: Genomic tools permit a detailed analysis of antibiotic resistance determinants in bacteria, or resistome. Here we discuss variations in antibiotic resistance in K. pneumoniae (Kp) not explained by changes in the resistome METHODS: We compared Kp strains with divergent carbapenem and aminoglycoside susceptibilities. After identification of bacteria, antibiotic susceptibility testing was performed according to CLSI guidelines. Draft genome sequences were generated using Illumina MiSeq (Nextera paired-end library) and assembled using CLC Genomics Workbench (CLC bio, Cambridge, MA). Resistome, plasmid types and MLST were investigated using the CGE platform (http://cge.cbs.dtu.dk), while capsular type and virulence genes were investigated using the Pasteur BIGsDB database (https://bigsdb.pasteur.fr). RESULTS: While receiving amoxicillin-clavulanate, a 44-year old man with diabetes mellitus and paraplegia with neurogenic bladder grewKp resistant to carbapenems and amikacin from urine. He was treated with fosfomycin and amikacin, followed by imipenem and plazomicin, prior to lithotripsy. Three months later, while off antibiotics, urine cultures grew Kp susceptible to carbapenems and amikacin (figure). Genetic comparison between resistant (November 20, 2018) and susceptible (January 30, 2019) strains revealed they were isogenic, only differing by 559 SNPs (table). Both were ST14, presented capsular type 16, and shared cehalosporinase (bla(SHV-28), bla(CTX-M-15), bla(TEM-1B), bla(OXA-1)) and aminoglycoside modifying enzyme (AME) (aph(3’’)-Ib, aph(6)-Id, aac(6’)-Ib-cr) genes. Although both had mutations in the outer membrane porin OmpK36, these differed (stop AA125 and frameshift AA183, respectively) CONCLUSION: Carbapenem resistance in the initial Kp is likely explained by overexpression of cephalosporinases in combination with changes in membrane permeability, while amikacin resistance is likely due to AMEs. Since no significant gene variation was observed in the susceptible Kp, reversal of resistance was likely due to decreased expression of cephalosporinases and AMEs after antibiotics were stopped. Incorporation of antibiotic history and host factors can explain clinically important changes in antibiotic resistance [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810522/ http://dx.doi.org/10.1093/ofid/ofz360.309 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Rojas, Laura J Marshall, Steven Yasmin, Mohamad Rudin, Susan D Perez, Federico Donskey, Curtis Hecker, Michelle Bonomo, Robert A 234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria |
title | 234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria |
title_full | 234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria |
title_fullStr | 234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria |
title_full_unstemmed | 234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria |
title_short | 234. Reversal of Carbapenem and Amikacin Susceptibilities in Isogenic Klebsiella pneumoniae From a Patient with Persistent Bacteriuria |
title_sort | 234. reversal of carbapenem and amikacin susceptibilities in isogenic klebsiella pneumoniae from a patient with persistent bacteriuria |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810522/ http://dx.doi.org/10.1093/ofid/ofz360.309 |
work_keys_str_mv | AT rojaslauraj 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria AT marshallsteven 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria AT yasminmohamad 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria AT rudinsusand 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria AT perezfederico 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria AT donskeycurtis 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria AT heckermichelle 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria AT bonomoroberta 234reversalofcarbapenemandamikacinsusceptibilitiesinisogenicklebsiellapneumoniaefromapatientwithpersistentbacteriuria |